Medicare Launches Pilot Program for Weight-Loss Drug Coverage Starting July 1

Want the full story?
Read the complete article at KVIA
AI Summary
Beginning July 1, Medicare will introduce a pilot program called Medicare GLP-1 Bridge, allowing eligible enrollees to access weight-loss medications at significantly reduced prices. This program addresses the financial burden of drugs like Wegovy and Zepbound, which can cost over $1,000 monthly. Eligibility criteria include specific body mass index (BMI) thresholds and health conditions, impacting millions of seniors who struggle with obesity-related issues. The initiative is part of a broader effort to treat obesity as a medical condition deserving of coverage. Interested individuals should consult their doctors to determine eligibility and obtain necessary prescriptions.
Key Details: • Program starts on July 1, 2023. • Eligible participants must have a BMI of 27 or higher with specific health conditions. • Participants must have Medicare Part D coverage and complete a prior authorization form. • Consult with your doctor to check eligibility and obtain prescriptions.